<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19710278</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>10</Issue><PubDate><Year>2009</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>Monoclonal antibodies to VP1 recognize a broad range of enteroviruses.</ArticleTitle><Pagination><StartPage>3108</StartPage><EndPage>3113</EndPage><MedlinePgn>3108-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.00479-09</ELocationID><Abstract><AbstractText>Enteroviruses (EVs) are common seasonal viruses that are associated with a variety of diseases. High-quality monoclonal antibodies (MAbs) are needed to improve the accuracy of EV diagnosis in clinical laboratories. In the present study, the full-length VP1 genes of poliovirus 1 (Polio 1) and coxsackievirus B3 (Cox B3) were cloned, and the encoded proteins were expressed and used as antigens in an attempt to raise broad-spectrum MAbs to EVs. Two pan-EV MAbs were isolated: one raised against Polio 1 VP1 and the other against Cox B3 VP1. The binding sites of both pan-EV MAbs were mapped to an amino acid sequence within a conserved region in the N terminus of Polio 1 VP1 by peptide and competition enzyme-linked immunosorbent assay. Two additional MAbs, an EV70-specific MAb and an EV71/Cox A16-bispecific MAb, developed against EV70 and 71 VP1 proteins, were pooled with the two pan-EV MAbs (pan-EV MAb mix) and tested for their sensitivity and specificity in the staining of various virus-infected cells. The pan-EV MAb mix detected all 40 prototype EVs tested and showed no cross-reactivity to 18 different non-EV human viruses. Compared with two commercially available EV tests, the pan-EV MAb mix exhibited higher specificity than one test and broader spectrum reactivity than the other. Thus, our study demonstrates that full-length Polio 1 VP1 and Cox B3 VP1 can serve as effective antigens for developing a pan-EV MAb and that the pan-EV MAb mix can be used for the laboratory diagnosis of a wide range of EV infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Lynn Yihong</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>R&amp;D Department, Diagnostic Hybrids, Inc., Athens, OH 45701, USA. miao@dhiusa.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierce</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Gray-Johnson</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>DeLotell</LastName><ForeName>Jill</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Carl</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Chapman</LastName><ForeName>Nate</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Elaine</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Schnurr</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yung T</ForeName><Initials>YT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C442540">VP1 protein, Poliovirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015678">Viral Structural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017124" MajorTopicYN="N">Conserved Sequence</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015678" MajorTopicYN="N">Viral Structural Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>8</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>8</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2010</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19710278</ArticleId><ArticleId IdType="pmc">PMC2756915</ArticleId><ArticleId IdType="doi">10.1128/JCM.00479-09</ArticleId><ArticleId IdType="pii">JCM.00479-09</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blomqvist, S., C. Savolainen, L. Raman, M. Roivainen, and T. Hovi. 2002. Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J. Clin. Microbiol. 40:4218-4223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC139630</ArticleId><ArticleId IdType="pubmed">12409401</ArticleId></ArticleIdList></Reference><Reference><Citation>Cello, J., A. Samuelson, P. Stalhandske, B. Svennerholm, S. Jeansson, and M. Forsgren. 1993. Identification of group-common linear epitopes in structural and nonstructural proteins of enteroviruses by using synthetic peptides. J. Clin. Microbiol. 31:911-916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC263586</ArticleId><ArticleId IdType="pubmed">7681848</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. 1997. Enterovirus surveillance&#x2014;Unites States, 1993-1996. MMWR Morb. Mortal. Wkly. Rep. 46:748-750.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. 2000. Enterovirus surveillance&#x2014;Unites States, 1997-1999. MMWR Morb. Mortal. Wkly. Rep. 49:913-916.</Citation><ArticleIdList><ArticleId IdType="pubmed">11043646</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. 2002. Enterovirus surveillance&#x2014;Unites States, 2000-2001. MMWR Morb. Mortal. Wkly. Rep. 51:1047-1049.</Citation><ArticleIdList><ArticleId IdType="pubmed">12487527</ArticleId></ArticleIdList></Reference><Reference><Citation>Galfre, G., S. C. Howe, C. Milstein, G. W. Butcher, and J. C. Howard. 1977. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266:550-552.</Citation><ArticleIdList><ArticleId IdType="pubmed">558524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovi, T., and M. Roivainen. 1993. Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus. J. Clin. Microbiol. 31:1083-1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC262883</ArticleId><ArticleId IdType="pubmed">8388885</ArticleId></ArticleIdList></Reference><Reference><Citation>Klespies, S. L., D. E. Cebula, C. L. Kelley, D. Galehouse, and C. C. Maurer. 1996. Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay. J. Clin. Microbiol. 34:1465-1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC229043</ArticleId><ArticleId IdType="pubmed">8735099</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipson, S. M., K. David, F. Shaikh, and L. Qian. 2001. Detection of precytopathic effect of enteroviruses in clinical specimens by centrifugation-enhanced antigen detection. J. Clin. Microbiol. 39:2755-2759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88235</ArticleId><ArticleId IdType="pubmed">11473988</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitreyi, R. S., L. Dar, A. Muthukumar, M. Vajpayee, I. Xess, R. B. Vajpayee, P. Seth, and S. Broor. 1999. Acute hemorrhagic conjunctivitis due to enterovirus 70 in India. Emerg. Infect. Dis. 5:267-269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2640696</ArticleId><ArticleId IdType="pubmed">10221880</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste, M. S., K. Maher, D. Schnurr, M. R. Flemister, J. C. Lovchik, H. Peters, W. Sessions, C. Kirk, N. Chatterjee, S. Fuller, J. M. Hanauer, and M. A. Pallansch. 2004. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J. Gen. Virol. 85:2577-2584.</Citation><ArticleIdList><ArticleId IdType="pubmed">15302951</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste, M. S., S. Penaranda, K. Maher, and M. A. Pallansch. 2004. Complete genome sequences of all members of the species Human enterovirus A. J. Gen. Virol. 85:1597-1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">15166444</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios, G., and M. S. Oberste. 2005. Enteroviruses as agents of emerging infectious diseases. J. Neurovirol. 11:424-433.</Citation><ArticleIdList><ArticleId IdType="pubmed">16287683</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch, M., and R. Roos. 2007. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 839-894. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott Williams and Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Rigonan, A. S., L. Mann, and T. Chonmaitree. 1998. Use of monoclonal antibodies to identify serotypes of enterovirus isolates. J. Clin. Microbiol. 36:1877-1881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104944</ArticleId><ArticleId IdType="pubmed">9650928</ArticleId></ArticleIdList></Reference><Reference><Citation>Roivainen, M., L. Piirainen, T. Rysa, A. Narvanen, and T. Hovi. 1993. An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution. Virology 195:762-765.</Citation><ArticleIdList><ArticleId IdType="pubmed">8393243</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson, A., M. Forsgren, and M. Sallberg. 1995. Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin. Diagn. Lab. Immunol. 2:385-386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC170165</ArticleId><ArticleId IdType="pubmed">7545081</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin, S. Y., K. S. Kim, Y. S. Lee, Y. S. Chung, K. S. Park, D. S. Cheon, B. K. Na, Y. Kang, H. M. Cheong, Y. Moon, J. H. Choi, H. E. Cho, N. Y. Min, J. S. Son, Y. H. Park, Y. Jee, J. D. Yoon, C. Y. Song, and K. H. Lee. 2003. Identification of enteroviruses by using monoclonal antibodies against a putative common epitope. J. Clin. Microbiol. 41:3028-3034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165318</ArticleId><ArticleId IdType="pubmed">12843038</ArticleId></ArticleIdList></Reference><Reference><Citation>Terletskaia-Ladwig, E., S. Meier, R. Hahn, M. Leinmuller, F. Schneider, and M. Enders. 2008. A convenient rapid culture assay for the detection of enteroviruses in clinical samples: comparison with conventional cell culture and RT-PCR. J. Med. Microbiol. 57:1000-1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">18628502</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu, P. V., N. T. Thao, D. Perera, T. K. Huu, N. T. Tien, T. C. Thuong, O. M. How, M. J. Cardosa, and P. C. McMinn. 2007. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg. Infect. Dis. 13:1733-1741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, S. M., C. C. Liu, H. W. Tseng, J. R. Wang, C. C. Huang, Y. J. Chen, Y. J. Yang, S. J. Lin, and T. F. Yeh. 1999. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29:184-190.</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi, S., D. Schnurr, and J. Lin. 1992. Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies. J. Clin. Microbiol. 30:2498-2501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC265534</ArticleId><ArticleId IdType="pubmed">1328290</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef, G. E., I. N. Brown, and J. F. Mowbray. 1987. Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology 28:163-170.</Citation><ArticleIdList><ArticleId IdType="pubmed">2836335</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>